SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Hypothesis: Mechanistic Proposal: Pathologic synergy: The pathologic agg

hypothesis 3,003 words KG: kinases 2026-03-26

kind:hypothesis section:hypotheses state:published

Contents

Mechanistic Proposal: Pathologic synergy: The pathologic aggregation of...

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Smartphone-Detected Motor Variability Correction
Score: 0.56 Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55 Dual-Circuit Tau Vulnerability Cascade
Score: 0.50 Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49

Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45 Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 APOE-Dependent Autophagy Restoration
Score: 0.61 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 Cell-Type Specific TFEB Modulation
Score: 0.48 APOE-TREM2 Interaction Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 APOE Isoform Conversion Therapy
Score: 0.44 TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40 TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40

Related Analyses (15)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived

Related Experiments (18)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90 Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90 Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85 Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80

TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80 LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40 Trehalose-induced lysosomal changes and TFEB activation
exploratory · proposed · Score: 0.90 Trehalose-induced lysosomal membrane permeabilization and TF
exploratory · proposed · Score: 0.90 Functional validation of trehalose effects on misfolded prot
exploratory · proposed · Score: 0.85 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40

Knowledge Graph (1 edges)

kinases regulates signaling_pathways

SciDEX — scidex.ai — Dashboard | Atlas